COVID-19 Related News
CRP rapid testing for suspected COVID-19 could slow the spread of antimicrobial resistance
Dr Carl Llor reviews recent evidence that C-reactive protein (CRP) rapid testing can be used as a prognostic marker in COVID-19 and contribute to...
Effectively mitigating the impacts of mucormycosis
Martin Hoenigl, the President of the European Confederation of Medical Mycology, discusses the challenges of diagnosing and treating mucormycosis.
Mucormycosis is perhaps not a term...
Harnessing the benefits of UVA light treatment in COVID-19 patients
Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
SARS-CoV-2 Delta variant causes twice the hospitalisations of Alpha
A novel study has revealed that the SARS-CoV-2 Delta variant may be the deadliest, demonstrating a two-fold increased risk of hospitalisation compared to the...
Point-of-care medicine: the future of rapid diagnostics in healthcare
Abbott explores how point-of-care diagnostics will evolve in the wake of COVID-19, and showcases a new learning platform that aims to transform knowledge on rapid testing in primary care.
Trial begins for world-first multivariant COVID-19 vaccine booster
A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester.
Initiated by pharmaceutical company Gritstone, in partnership with...
ASAP Innovations: Pioneers of the personal protective equipment industry
As the COVID-19 crisis has evolved and the pandemic has just about taken its toll on almost every sector across the globe, those working...
XPhyto Therapeutics’ biosensors: taking rapid testing to the next level
Testing for coronaviruses may soon take no more than a couple of minutes thanks to XPhyto’s enzyme-based biosensor diagnostic technology.
A Canadian-headquartered life sciences company...
Enhancing vaccine design with B lymphocytes discovery
Findings from a research study of B lymphocytes – otherwise known as B cells – may aid in advancing the design of future vaccines.
The...
Defence Therapeutics’ new COVID vaccine achieves successful testing
Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model.
The new COVID vaccine – called...
Health experts believe COVID-19 booster vaccines are not yet required
A group of industry-leading health experts has concluded that COVID-19 booster vaccines are not yet needed to combat the pandemic.
The international team of scientists,...
Commonly prescribed gout medication found effective against COVID-19
A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon...
COVID-19 variants will require infection control measures post-vaccination
Even after the implementation of widespread vaccination protocols, robust infection control measures will need to be enforced to prevent the spread of COVID-19 variants,...
Frontline workers need better mental health support, experts say
Researchers have called for urgent improvements to mental health support for frontline healthcare workers in England.
A team of psychiatrists and psychologists from University College...
Long COVID risk reduced by almost half after double vaccine dose
Receiving two COVID-19 vaccine doses reduces a person’s risk of experiencing long COVID by almost half, a new study has shown.
Research led by King’s...
Organ transplants fell by a third during first wave of COVID-19
The number of solid organ transplants performed globally dropped by 31% during the first wave of the COVID-19 pandemic, a new study has revealed.
Research...
Experts warn COVID-19 recovery could take longer than a year
Around one half of patients who were hospitalised with COVID-19 still experience health issues related to the virus after one year, a study has...
Pfizer-BionNTech vaccine side effects mild to moderate in high-risk children
The side effects of the Pfizer-BionNTech vaccine in clinically vulnerable 12- to 15-year-olds are likely to be minimal, a study has shown.
In a small...
COVID-19 infection in pregnancy linked to higher risk of pre-eclampsia
Contracting COVID-19 during pregnancy can increase a woman’s risk of developing pre-eclampsia, researchers have demonstrated.
A review of scientific literature by researchers in Brazil has...
Prototype breathing device created for COVID-19 patients in poor countries
Experts have developed a low-cost and easy-to-use prototype breathing device, designed specifically for poorer-resourced healthcare settings.
Created in response to the surge of COVID-19 cases...